Test offers new way to personalize treatment, reduce unnecessary chemotherapy for patients with breast cancer

A caller crab diagnostic trial marketed by Veracyte and developed by a radical of researchers, including UNC geneticist Charles Perou, Ph.D., has been recovered to accurately foretell whether patients with bosom crab request chemotherapy oregon whether hormone therapy unsocial tin safely and efficaciously pb to remission.